Literature DB >> 25381463

The ascending median raphe projections are mainly glutamatergic in the mouse forebrain.

András Szőnyi1,2, Márton I Mayer1, Csaba Cserép1, Virág T Takács1, Masahiko Watanabe3, Tamás F Freund1, Gábor Nyiri4.   

Abstract

The median raphe region (MRR) is thought to be serotonergic and plays an important role in the regulation of many cognitive functions. In the hippocampus (HIPP), the MRR exerts a fast excitatory control, partially through glutamatergic transmission, on a subpopulation of GABAergic interneurons that are key regulators of local network activity. However, not all receptors of this connection in the HIPP and in synapses established by MRR in other brain areas are known. Using combined anterograde tracing and immunogold methods, we show that the GluN2A subunit of the NMDA receptor is present in the synapses established by MRR not only in the HIPP, but also in the medial septum (MS) and in the medial prefrontal cortex (mPFC) of the mouse. We estimated similar amounts of NMDA receptors in these synapses established by the MRR and in local adjacent excitatory synapses. Using retrograde tracing and confocal laser scanning microscopy, we found that the majority of the projecting cells of the mouse MRR contain the vesicular glutamate transporter type 3 (vGluT3). Furthermore, using double retrograde tracing, we found that single cells of the MRR can innervate the HIPP and mPFC or the MS and mPFC simultaneously, and these double-projecting cells are also predominantly vGluT3-positive. Our results indicate that the majority of the output of the MRR is glutamatergic and acts through NMDA receptor-containing synapses. This suggests that key forebrain areas receive precisely targeted excitatory input from the MRR, which is able to synchronously modify activity in those regions via individual MRR cells with dual projections.

Entities:  

Keywords:  GABAergic interneurons; Hippocampus; Immunohistochemistry; Medial septum; Median raphe; Mouse; NMDA receptor; Non-serotonergic; Prefrontal cortex; Vesicular glutamate transporter type 3; vGluT3

Mesh:

Substances:

Year:  2014        PMID: 25381463      PMCID: PMC4426081          DOI: 10.1007/s00429-014-0935-1

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  52 in total

1.  High-resolution imaging of antibodies by tapping-mode atomic force microscopy: attractive and repulsive tip-sample interaction regimes.

Authors:  A San Paulo; R García
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

2.  Voltage-sensitivity of motoneuron NMDA receptor channels is modulated by serotonin in the neonatal rat spinal cord.

Authors:  J N MacLean; B J Schmidt
Journal:  J Neurophysiol       Date:  2001-09       Impact factor: 2.714

3.  Collateral projections from the median raphe nucleus to the medial septum and hippocampus.

Authors:  J T McKenna; R P Vertes
Journal:  Brain Res Bull       Date:  2001-04       Impact factor: 4.077

Review 4.  Multiple output pathways of the basal forebrain: organization, chemical heterogeneity, and roles in vigilance.

Authors:  K Semba
Journal:  Behav Brain Res       Date:  2000-11       Impact factor: 3.332

5.  Dendroarchitecture of relay cells in thalamic barreloids: a substrate for cross-whisker modulation.

Authors:  Caroline Varga; Attila Sík; Philippe Lavallée; Martin Deschênes
Journal:  J Neurosci       Date:  2002-07-15       Impact factor: 6.167

6.  Retention of NMDA receptor NR2 subunits in the lumen of endoplasmic reticulum in targeted NR1 knockout mice.

Authors:  Masahiro Fukaya; Akira Kato; Chanel Lovett; Susumu Tonegawa; Masahiko Watanabe
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-03       Impact factor: 11.205

7.  VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety.

Authors:  Bénédicte Amilhon; Eve Lepicard; Thibault Renoir; Raymond Mongeau; Daniela Popa; Odile Poirel; Stéphanie Miot; Christelle Gras; Alain M Gardier; Jorge Gallego; Michel Hamon; Laurence Lanfumey; Bruno Gasnier; Bruno Giros; Salah El Mestikawy
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

Review 8.  The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics.

Authors:  Christian A Heidbreder; Henk J Groenewegen
Journal:  Neurosci Biobehav Rev       Date:  2003-10       Impact factor: 8.989

9.  GABAergic basket cells expressing cholecystokinin contain vesicular glutamate transporter type 3 (VGLUT3) in their synaptic terminals in hippocampus and isocortex of the rat.

Authors:  Jozsef Somogyi; Agnès Baude; Yuko Omori; Hidemi Shimizu; Salah El Mestikawy; Masahiro Fukaya; Ryuichi Shigemoto; Masahiko Watanabe; Peter Somogyi
Journal:  Eur J Neurosci       Date:  2004-02       Impact factor: 3.386

10.  Non-serotonergic dorsal and median raphe projection onto parvalbumin- and calbindin-containing neurons in hippocampus and septum.

Authors:  S Aznar; Z-X Qian; G M Knudsen
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more
  18 in total

1.  Development- and experience-dependent plasticity in the dorsomedial habenula.

Authors:  Peter Koppensteiner; Christopher Galvin; Ipe Ninan
Journal:  Mol Cell Neurosci       Date:  2016-10-26       Impact factor: 4.314

2.  Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment.

Authors:  Valérie Turcotte-Cardin; Faranak Vahid-Ansari; Christine Luckhart; Mireille Daigle; Sean D Geddes; Kenji F Tanaka; René Hen; Jonathan James; Zul Merali; Jean-Claude Béïque; Paul R Albert
Journal:  J Neurosci       Date:  2018-12-14       Impact factor: 6.167

3.  Two Functionally Distinct Serotonergic Projections into Hippocampus.

Authors:  Alessandro Luchetti; Ayaka Bota; Adam Weitemier; Kotaro Mizuta; Masaaki Sato; Tanvir Islam; Thomas J McHugh; Ayumu Tashiro; Yasunori Hayashi
Journal:  J Neurosci       Date:  2020-05-15       Impact factor: 6.167

4.  Separable gain control of ongoing and evoked activity in the visual cortex by serotonergic input.

Authors:  Zohre Azimi; Ruxandra Barzan; Katharina Spoida; Tatjana Surdin; Patric Wollenweber; Melanie D Mark; Stefan Herlitze; Dirk Jancke
Journal:  Elife       Date:  2020-04-07       Impact factor: 8.140

5.  Neurochemically and Hodologically Distinct Ascending VGLUT3 versus Serotonin Subsystems Comprise the r2-Pet1 Median Raphe.

Authors:  Rebecca A Senft; Morgan E Freret; Nikita Sturrock; Susan M Dymecki
Journal:  J Neurosci       Date:  2021-02-05       Impact factor: 6.167

6.  Top-down projections of the prefrontal cortex to the ventral tegmental area, laterodorsal tegmental nucleus, and median raphe nucleus.

Authors:  Rudieri Souza; Debora Bueno; Leandro B Lima; Maria J Muchon; Luciano Gonçalves; Jose Donato; Sara J Shammah-Lagnado; Martin Metzger
Journal:  Brain Struct Funct       Date:  2022-07-22       Impact factor: 3.748

Review 7.  The role of inhibitory circuits in hippocampal memory processing.

Authors:  Lisa Topolnik; Suhel Tamboli
Journal:  Nat Rev Neurosci       Date:  2022-05-30       Impact factor: 38.755

8.  A Cooperative Mechanism Involving Ca2+-Permeable AMPA Receptors and Retrograde Activation of GABAB Receptors in Interpeduncular Nucleus Plasticity.

Authors:  Peter Koppensteiner; Riccardo Melani; Ipe Ninan
Journal:  Cell Rep       Date:  2017-08-01       Impact factor: 9.423

9.  Reciprocal Lateral Hypothalamic and Raphe GABAergic Projections Promote Wakefulness.

Authors:  Mary Gazea; Szabina Furdan; Péter Sere; Lukas Oesch; Benedek Molnár; Giuseppe Di Giovanni; Lief E Fenno; Charu Ramakrishnan; Joanna Mattis; Karl Deisseroth; Susan M Dymecki; Antoine R Adamantidis; Magor L Lőrincz
Journal:  J Neurosci       Date:  2021-04-22       Impact factor: 6.167

10.  Serotonin 5-HT1B receptor-mediated behavior and binding in mice with the overactive and dysregulated serotonin transporter Ala56 variant.

Authors:  Kally C O'Reilly; Michelle Connor; Jamie Pierson; Lauren C Shuffrey; Randy D Blakely; Susanne E Ahmari; Jeremy Veenstra-VanderWeele
Journal:  Psychopharmacology (Berl)       Date:  2021-01-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.